<DOC>
	<DOCNO>NCT01952847</DOCNO>
	<brief_summary>The goal clinical research study learn glutamine help control prevent sore , blister , inflammation mouth esophagus due current treatment . In study , glutamine compare placebo . A placebo drug . It look like drug design treat disease illness . It design compare study drug learn study drug real effect .</brief_summary>
	<brief_title>Randomized Trial Glutamine Patients With Mucositis Esophagitis</brief_title>
	<detailed_description>Study Groups : If find eligible take part study , randomly assign ( flip coin ) 1 2 study group . You equal chance assign either group : - If Group 1 , receive glutamine . - If Group 2 , receive placebo . Neither study staff know receive study drug placebo . However , need safety , study staff able find receiving . Study Drug Administration : Glutamine placebo take sugary drink mouth . You take drink twice daily start day first receive anti-cancer therapy radiation treatment . You mix one scoop powder 25-100 milliliter ( 2-6 tablespoon ) water . If chemotherapy group , swish drink 10 second swallow . If radiation group , swallow drink small amount several time . Study Visits : At every visit , ask side effect may drug may take . Chemotherapy Group : On Days 1 , 8 , 22 Cycle 1 : - You mouth exam . - Your weight record . On Day 15 Cycle 1 : - You mouth exam . - Your weight record . - You complete quality life questionnaire . On Day 1 Cycle 2 beyond : - You mouth exam . - Your weight record . - If doctor think need , blood ( 2 teaspoon ) draw routine test . - You complete quality life questionnaire . - You complete survey feel study drug . This take 5-10 minute complete . - If doctor think need , photograph mouth take . After 3 month chemotherapy : - You complete quality life questionnaire . After 6 month chemotherapy : - Your weight record . - You complete quality life questionnaire . Follow-Up : For follow-up questionnaire Day 1 every Cycle , 3 6 month , End-of-Study visit , may call study team . This call last 5-10 minute . Radiation Therapy Group : On Weeks 1 , 2 , 4 , 6 Radiation : - You ask inflammation esophagus . - Your weight record . - If doctor think need , blood ( 2 teaspoon ) draw routine test . On Weeks 3 5 Radiation : - You ask inflammation esophagus . - Your weight record . - If doctor think need , blood ( 2 teaspoon ) draw routine test . - You complete quality life questionnaire . - You complete survey feel study drug . On Week 7 Radiation : - You ask inflammation esophagus . - Your weight record . - If doctor think need , blood ( 2 teaspoon ) draw routine test . - You complete quality life questionnaire . - You complete survey feel study drug . 1 month radiation end : - You ask inflammation esophagus . - Your weight record . - If doctor think need , blood ( 2 teaspoon ) draw routine test . - You complete quality life questionnaire . - You complete survey feel study drug . 3 month radiation end : - You complete quality life questionnaire . Follow-Up : For follow-up questionnaire 1 3 month End-of-Study visit , may call study team . This call last 5-10 minute . Length Study : You may continue take study drug long doctor think best interest . You continue take glutamine placebo 4 week completion anti-cancer therapy radiation treatment . If stop chemotherapy radiation completion intend study period , continue take study drug 4 week . If develop severe sore , blister , inflammation mouth esophagus , remove study , doctor give another medication sores blister . Your participation study 6 month completion therapy . End-of-Study Visit : After study , end-of-study visit . For radiation group , 6 month radiation therapy . For chemotherapy group , 4 week last dose . - Your weight record . - If doctor think need , blood ( 2 teaspoon ) draw routine test . - You complete quality life questionnaire . - If chemotherapy group , mouth exam . This investigational study . Glutamine FDA approve commercially available treatment short bowel syndrome . Its use treat mouth sores inflammation esophagus investigational . Up 180 patient take part study . All enrol MD Anderson .</detailed_description>
	<mesh_term>Mucositis</mesh_term>
	<mesh_term>Esophagitis</mesh_term>
	<mesh_term>Everolimus</mesh_term>
	<mesh_term>Sirolimus</mesh_term>
	<criteria>1 . Patients initiate therapy investigatorinitiated mTOR inhibitor base therapy Department Investigational Cancer Therapeutics ( Phase I Program ) initiate radiation therapy esophagus . 2 . For esophagitis arm , patient thoracic malignancy , receive radiation alone concurrent chemo/radiation . Radiation dose must &gt; /= 45 Gy . For esophagitis arm , induction chemotherapy allow . 3 . Ability understand willingness sign write informed consent . A sign informed consent must obtain prior study specific procedure . 4 . Patients must &gt; /= 17 year age . 5 . Females childbearing potential must negative pregnancy test . Sexually active patient must agree use contraception prior , , 30 day last dose . 1 ) Patients currently receive therapy mucositis .</criteria>
	<gender>All</gender>
	<minimum_age>17 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Advanced Cancers</keyword>
	<keyword>Mucositis</keyword>
	<keyword>Esophagitis</keyword>
	<keyword>mTOR Inhibitor-based Regimen</keyword>
	<keyword>Radiation Esophagus</keyword>
	<keyword>Thoracic malignancy</keyword>
	<keyword>Placebo</keyword>
	<keyword>Glutamine</keyword>
	<keyword>Enterex</keyword>
	<keyword>Glutapak-10</keyword>
	<keyword>NutreStore</keyword>
	<keyword>Resource</keyword>
	<keyword>GlutaSolve</keyword>
	<keyword>Sympt-X G.I .</keyword>
	<keyword>Sympt-X</keyword>
	<keyword>Questionnaires</keyword>
	<keyword>Surveys</keyword>
</DOC>